Please note: This review reflects information we gathered on the date it was researched and may now be out of date. Providers frequently change their pricing, plans, medications, and policies. Any ratings, reviews, and customer feedback are gathered from publicly available online sources and may have since changed or no longer be accurate. Always do your own research and confirm the latest details directly with the provider before making any decision.
Five CBD Review
The third brand from the same owner we have tested this month on one simple question: can you open a lab certificate? Vena could not. Medterra could not. Nor can this one.
Five CBD
No Retrievable CertificatesNot a weight-loss product: these are intoxicating THC products and THC increases appetite. If you came to compare treatment, our provider rankings are the page you want.
Five is a Medterra-owned hemp brand. Checked on 7 August 2026 it listed 43 products from $14.99 to $146.96, median $55.99 — and 30 of the 43 are THC-named, so despite the name this is an intoxicating-hemp business rather than a CBD one.
Its transparency page reads: 'five's committed to brand transparency... we provided third-party lab testing results on all our products'. We could not open one. No PDFs, no batch selector, no laboratory named; the search box turned out to be Shopify's ordinary product search; and the product page links loop back to that same page. Zero certificate requests were made across the whole session.
What makes this worth a headline rather than a footnote: Vena, Medterra and Five are all Medterra CBD LLC, we tested each independently this month, and all three failed the same way. One broken page is an oversight. Three is a description of how the group works.
Credit where it is due: the dose ladder is sensible. Options at 2mg, 5mg, 10mg and 15mg THC mean a cautious buyer can genuinely start low, which much of this category does not allow. And drug testing is acknowledged rather than buried.
Affiliate disclosure: GLP1Drugs.org earns a commission if you buy through the links on this page — 40% on this programme. We tested the certificate claim three separate ways before concluding, and reported the result across all three of this owner's brands. Verified 7 August 2026.
Visit Five CBDOur Top Recommended Provider: CoreAge Rx
After reviewing dozens of GLP-1 telehealth providers, CoreAge Rx is the one we recommend most. CoreAge Rx is one of our partners — read on for why we recommend them:
Flat-Rate Pricing
Same cost at every dose level — no price jumps as you titrate up.
Verified Pharmacies
US-licensed physicians and NABP-verified 503A compounding pharmacies you can trust.
Everything Included
Medication, supplies, free shipping, and ongoing clinical support — no hidden fees.
Active Community of Members
Ask questions, share progress, and get answers from other patients on the same journey — alongside ongoing clinical support from your care team.
0
Certificates We Could Open
3 / 3
Sister Brands With The Same Gap
None
Trustpilot Profile At All
2mg
Lowest Dose — A Real Positive
How We Tested It
Three routes, one result. We would rather show the method than assert the conclusion.
The Promise Is Identical
'five's committed to brand transparency. to live up to that, we provided third-party lab testing results on all our products' — near-identical wording to its two sister brands
The Page Holds Nothing
No PDF links, no batch selector, no laboratory named. Across the whole session our browser made zero requests for a certificate file
The Search Box Is Not A Batch Lookup
It looked promising, but it is Shopify's ordinary site search — the input is named 'q' and it returns products, not certificates
Product Pages Loop Back
Every certificate link on the product page we opened points straight back to the certificates page. The same circular reference we found at Medterra
Three Brands, One Owner
Vena, Medterra and Five are all Medterra CBD LLC. We tested each independently with the same method and got the same result three times
Which Makes It Systematic
One broken page is an oversight. The same failure across an entire portfolio is how the company operates, and it is the single thing we would want fixed
One Owner, Three Brands
All three are Medterra CBD LLC. We reviewed each separately this month using the same test.
| Brand | Rating | Certificate we could open | Returns | Independent record |
|---|---|---|---|---|
| Five CBD | 3.0 | None | 30 days, unopened only | No Trustpilot profile |
| Medterra | 3.5 | None — links loop | 30 days, opened product allowed | 4.4 (325) |
| Vena CBD | 3.2 | None | 30 days, you pay postage | 4.0 (100) |
For contrast, outside this group: Koi publishes 193 batch certificates you can open by matching the number on your packaging, and CBDfx around 50 per product from a named ISO 17025 laboratory with its accreditation number printed on the report. It is clearly achievable.
Pros & Cons
Pros
- ✓Dosing is genuinely graduated — 2mg, 5mg, 10mg and 15mg THC options mean a cautious buyer can start low
- ✓A 2mg THC gummy is a responsible entry point that much of this category does not offer
- ✓Drug testing is acknowledged on the site rather than glossed over
- ✓A 30-day return window, with a prepaid return label issued if the return is accepted
- ✓Reasonable pricing: 43 products from $14.99 to $146.96 with a median of $55.99
- ✓Part of an established group rather than a storefront that appeared last quarter
Cons
- ✕We could not retrieve a single certificate of analysis, despite a page dedicated to promising them
- ✕No testing laboratory is named anywhere in that chain
- ✕This is the third Medterra-owned brand we have tested with exactly this failure, after Vena and Medterra itself
- ✕Returns require items 'unworn or unused, with tags, and in its original packaging' — you cannot try it and send it back
- ✕That is worse than sister brand Medterra, which lets new customers return an opened product
- ✕There is no Trustpilot profile for the domain at all, so no independent review record exists
- ✕Thirty of 43 products are THC-named, so most of the catalogue faces the 12 November 2026 hemp redefinition
- ✕The parent is subject to a publicly disclosed non-binding letter of intent to merge with Splash Beverage Group
- ✕Nothing here is a weight-loss product, and THC increases appetite
Our Verdict
3.0 / 5 — sensible dosing and honest drug-test disclosure, on a brand that will not show you a lab report, has no independent review record, and only takes returns unopened.
There are real positives and we do not want to bury them. The dose ladder is the best thing here: 2mg, 5mg, 10mg and 15mg options mean somebody new to edibles can start at a genuinely cautious dose, which a lot of this industry does not permit — the brands selling 30mg as an entry point are doing their customers no favours. Drug testing is acknowledged rather than hidden. The 30-day window comes with a prepaid label. Prices are unremarkable in a good way, with a median around $56.
Against that, the thing we grade hardest in this category is missing, and missing in a way that is now clearly systematic. Five publishes a page promising third-party lab results on all its products and we could not open one by any of three routes. Its sister brands Vena and Medterra, both owned by Medterra CBD LLC, failed identically when we tested them separately this month. Meanwhile two unrelated competitors let you download batch certificates in a couple of clicks, one of them from a named ISO 17025 laboratory. Add the absence of any Trustpilot profile, a returns policy that will not take an opened product, and thirty of forty-three items facing the November 2026 hemp redefinition, and there is very little here you can verify from the outside. If you want to try it, buy the 2mg gummies, buy the smallest pack, and email support for the certificate matching your batch before you open it. If they send one, that is the single most useful thing this company could do.
Visit Five CBDFrequently Asked Questions
Can you see a certificate of analysis?
No, and this is now a pattern rather than a one-off. Five has a page headed 'let's talk product transparency' which states: 'five's committed to brand transparency. to live up to that, we provided third-party lab testing results on all our products to ensure that consumers and regulatory bodies can easily access all of our product information.' We tested it three ways. The page itself carries no PDF links, no batch selector and names no laboratory. There is a search box, which looked promising until we inspected it — it is Shopify's ordinary site search, the input is named 'q', and it returns products rather than certificates. And the product page we opened links back to the certificates page, the same circular reference we found at its sister brand. Across the entire session our browser made zero requests for a certificate file. As always, we report a failure to retrieve rather than proof that testing never happens; reports could load through a mechanism our tools did not trigger. But a customer following the site's own instructions finds nothing.
Why does it matter that this is the third brand?
Because it changes what the finding means. Vena, Medterra and Five CBD are all owned by Medterra CBD LLC, and we reviewed each independently this month using the same method: go to the page that promises lab results, try to open one. Vena's page promised 'detailed third-party lab reports' and yielded none. Medterra's certificates page said reports live on product pages, and the product pages linked back to the certificates page. Five does the same thing with near-identical wording. One broken page is an oversight worth a sentence. The same failure across three brands under one owner is a description of how the company handles the single document that connects a label to its contents. Contrast it with what is achievable: one competitor lists 193 batch certificates you can open by matching the number on your own packaging, and another publishes around 50 per product from a named ISO 17025 laboratory with its accreditation number on the page. That is the standard, and this group is not meeting it anywhere in its portfolio.
What does it cost and what can you buy?
Checked on 7 August 2026, the live catalogue held 43 products from $14.99 to $146.96 with a median of $55.99, and 30 of the 43 are THC-named — so despite the brand name this is predominantly an intoxicating-hemp business rather than a CBD one. Representative items: a Quick Hits tin at $14.99, 10-count high-dose gummies at $24.99, a fast-acting 10mg THC seltzer variety pack at $39.99, a 15mg THC gummy variety pack at $89.22, and bundles above $100. The doses on offer run 2mg, 5mg, 10mg and 15mg of THC, which is a genuinely sensible ladder — a 2mg gummy is a cautious starting point and plenty of competitors do not offer one. If you are new to edibles, that is the one to buy, and the availability of it is a point in the brand's favour.
What is the return policy?
Thirty days, but unopened only, which is the weaker end of what this group offers. The published policy states you have '30 days after receiving your item to request a return', and that to be eligible 'your item must be in the same condition that you received it, unworn or unused, with tags, and in its original packaging'. If a return is accepted the company sends a prepaid label, and items posted back without requesting a return first are refused. That is a perfectly normal ecommerce policy, but it means you cannot try the product and return it if it does nothing — which for a consumable bought on the promise of an effect is the return that actually matters. Its sister brand Medterra gives new customers a risk-free trial that explicitly permits returning an opened product; Five does not. Another competitor allows returns at full value for 90 days. Buy the smallest size first.
Is there any independent review record?
None that we could find, which is unusual for a brand this size. There is no Trustpilot profile for enjoyfive.com at all — not a low score, simply no profile. That leaves you with on-site reviews, which the company controls, and no third-party signal to weigh them against. For comparison, we verified Medterra at 4.4 across 325 Trustpilot reviews and Vena at 4.0 across 100, so the absence here is specific to this brand rather than to the group. It is not evidence of anything bad in itself; plenty of decent companies never accumulate a profile. But combined with certificates you cannot open, it means there is very little external information available about this brand, and you would be buying largely on the strength of its own marketing.
What happens to these products in November 2026?
Most of the catalogue is affected. On 12 November 2025 the President signed H.R. 5371, which from 12 November 2026 redefines hemp as containing no more than 0.3% total THC on a dry weight basis, explicitly inclusive of THCA and delta-8, and caps a hemp consumable at 0.4mg of total THC per container. A single 15mg THC gummy is roughly 37 times that per-container limit before you count the rest of the pack, and 30 of Five's 43 live products are THC-named. The U.S. Hemp Roundtable has estimated the standard renders about 95% of existing hemp cannabinoid products federally unlawful. Whatever else you decide, do not start a recurring subscription on the intoxicating range with that date three months away.
Will these show up on a drug test?
Yes, and to the brand's credit drug testing is acknowledged on the site rather than glossed over. These products contain real Delta-9 THC — 2mg to 15mg per serving depending on the item — and hemp-derived Delta-9 is chemically the same molecule a urine screen detects. Being federally compliant on a dry-weight basis has no bearing on whether you test positive. If you are subject to workplace, custody, probation or athletic testing, do not buy anything from the THC part of this catalogue, which is most of it.
Who should not use these?
Anyone under 21. Anyone pregnant, trying to conceive or breastfeeding. Anyone with a personal or family history of psychosis, schizophrenia or bipolar disorder, since THC can precipitate psychiatric symptoms. Anyone with significant cardiovascular disease, given THC's effect on heart rate. Anyone driving or operating machinery within several hours of a dose, and anyone subject to drug testing. Anyone taking sedatives, benzodiazepines, opioids or alcohol, because the effects compound. If you take a GLP-1 receptor agonist, raise it with your prescriber: THC increases appetite, which works against the medication, and both affect the gut. This page is information, not medical advice.
Start At 2mg, Ask For The Certificate
The low-dose option is genuinely good practice. The lab report is not where the site says it is — email support for the one matching your batch before you open anything.
Visit Five CBDCompare Other GLP-1 Providers
See how other telehealth providers stack up.
Form Health
Comprehensive ProgramMultidisciplinary obesity medicine program with physicians, dietitians, and behavioral coaching
Read Review →Henry Meds
Top RatedWell-established telehealth platform with fast physician reviews and competitive pricing
Read Review →Boston Medical Group
Top RatedEstablished telehealth provider with physician oversight and transparent pricing
Read Review →JumpstartMD
Comprehensive ProgramMedically supervised program with obesity medicine physicians, dietitians, and in-person options
Read Review →CoreAge Rx
#1 RecommendedFlat-rate pricing for compounded semaglutide and tirzepatide with NABP-verified pharmacies
Read Review →PlushCare
Insurance AcceptedMajor telehealth platform with brand-name FDA-approved GLP-1s, insurance support, and 1M+ members treated
Read Review →Medical Disclaimer: This page is informational and is not medical advice. These are intoxicating hemp products for adults 21 and over, not treatments for any condition and not weight-management aids. THC impairs coordination, judgement and reaction time, may trigger anxiety or psychotic symptoms in susceptible people, will show up on a standard drug test, and compounds the effects of alcohol, sedatives, benzodiazepines and opioids. Oral THC has a delayed onset and is easy to overshoot; start at the lowest available dose. Do not use in pregnancy, while trying to conceive, or while breastfeeding, and do not drive or operate machinery after a dose. If you take a GLP-1 receptor agonist, discuss cannabinoid use with your prescriber: THC increases appetite and both affect gastric motility.
Date reviewed: 7 August 2026. The 43-product catalogue, prices, dose options and the quoted transparency wording were taken from Five's own site and product data on that date and may change. We attempted to retrieve a certificate of analysis by three routes — the dedicated certificates-of-analysis page, its on-page search box, and the certificate links on a product page — and obtained none; the page carried no PDF links, no batch selector and no named laboratory, the search box proved to be Shopify's standard product search with input name 'q', the product-page links returned to the certificates page, and no certificate file was requested during the session. As with our reviews of the sister brands, this is reported as a failure to retrieve rather than proof that testing does not occur. The return policy quoted — 30 days from receipt, items 'unworn or unused, with tags, and in its original packaging', prepaid label issued on acceptance, unrequested returns refused — is from the company's own refund policy. No Trustpilot profile was found for enjoyfive.com. Five CBD, Medterra and Vena are all brands of Medterra CBD LLC, each reviewed separately this month; Splash Beverage Group has publicly disclosed a non-binding letter of intent for a proposed merger with Medterra CBD, LLC, which may not complete. The federal hemp redefinition was enacted in H.R. 5371, signed 12 November 2025, effective 12 November 2026.
Affiliate Disclosure: This site may receive compensation from affiliate partners. This does not influence our editorial content or review ratings.